Tracking Gilead's 4 Big Stories and a Lawsuit in 2022

In this clip from "The Pharma & Biotech Show" on Motley Fool Live, recorded on Feb. 2, Motley Fool contributors Brian Orelli and Keith Speights discuss the major lawsuit between Gilead (NASDAQ:GILD) and [GlaxoSmithKline (LSE:GSK) majority-owned] ViiV Healthcare and analyze what effects the resulting settlement might have on future profits.